Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLubel, John S-
dc.contributor.authorRoberts, Stuart K-
dc.contributor.authorStrasser, Simone I-
dc.contributor.authorThompson, Alexander J-
dc.contributor.authorPhilip, Jennifer-
dc.contributor.authorGoodwin, Mark D-
dc.contributor.authorClarke, Stephen-
dc.contributor.authorCrawford, Darrell Hg-
dc.contributor.authorLevy, Miriam T-
dc.contributor.authorShackel, Nick-
dc.identifier.citationMedical Journal of Australia 2020; online first: 13 Decemberen
dc.description.abstractHepatocellular carcinoma (HCC) is a leading cause of cancer deaths both globally and in Australia. Surveillance for HCC in at-risk populations allows diagnosis at an early stage, when potentially curable. However, most Australians diagnosed with HCC die of the cancer or of liver disease. In the changing landscape of HCC management, unique challenges may lead to clinical practice variation. As a result, there is a need to identify best practice management of HCC in an Australian context. This consensus statement has been developed for health professionals involved in the care of adult patients with HCC in Australia. It is applicable to specialists, general medical practitioners, nurses, health coordinators and hospital administrators. This statement has been developed by specialists in hepatology, radiology, surgery, oncology, palliative care, and primary care, including medical practitioners and nurses. The statement addresses four main areas relevant to HCC management: epidemiology and incidence, diagnosis, treatment, and patient management. A modified Delphi process was used to reach consensus on 31 recommendations. Principal recommendations include the adoption of surveillance strategies, use of multidisciplinary meetings, diagnosis, treatment options and patient management. This consensus statement will simplify HCC patient management and reduce clinical variation. Ultimately, this should result in better outcomes for patients with HCC.en
dc.subjectLiver cirrhosisen
dc.subjectLiver neoplasmsen
dc.titleAustralian recommendations for the management of hepatocellular carcinoma: a consensus statementen
dc.typeJournal Articleen
dc.identifier.journaltitleMedical Journal of Australiaen
dc.identifier.affiliationAustin Healthen
dc.identifier.affiliationSurgery (University of Melbourne)en
dc.identifier.affiliationAlfred Health, Melbourne, VICen
dc.identifier.affiliationMonash University, Melbourne, VIC.en
dc.identifier.affiliationAW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, NSWen
dc.identifier.affiliationUniversity of Sydney, Sydney, NSWen
dc.identifier.affiliationSt Vincent's Hospital, Melbourne, VICen
dc.identifier.affiliationRoyal Melbourne Hospital, Melbourne, VICen
dc.identifier.affiliationRoyal North Shore Hospital, Sydney, NSWen
dc.identifier.affiliationGreenslopes Private Hospital, University of Queensland, Brisbane, QLDen
dc.identifier.affiliationLiverpool Hospital Sydney, Sydney, NSWen
dc.identifier.affiliationUniversity of New South Wales, Sydney, NSWen
dc.type.austinJournal Articleen
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jun 21, 2021

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.